Research Analyst at Horizons ETFs (Canada) Inc.
Member since: Oct '07 · 1335 Opinions
Markets appear to be recovering from weakness in April. Investors are cautious with under performance in tech since January. Will be interesting to see if trend in tech slowness will continue. Energy & industrial sectors appear to be benefiting from rotation. Defensive stocks appear to be the latest trend in investor tastes. Expecting strength in defensive sector as investors seek protection from "sell in May" traders. Will be opportunities in the spring/summer for stocks that have sold off. Four year election cycle will weigh on certain stocks - uncertain which sectors will benefit the most from spending by politicians looking to get re-elected.
Excellent name that offers defensive protection. Strength in health care sector good for investors. Weakness in sector that past 1-2 years is creating buying opportunity.
Another defensive name that is good for investors. A.I. demand along with Bitcoin driving need for energy. Large energy suppliers are seeing record growth. Expecting upward trend to continue. Falling interest rates will be good for utility balance sheets.
Yield curve indicating that interest rates are expecting. Will see value in this product. Expecting US Government bonds to breakout.
General position that is good for investors who are bullish on the market. Has recently began reducing position. Not as bullish as was at the start of the year.
Has recently sold position. Not as bullish on materials. Expecting rotation out of this sector. Material sector usually peaks in May.
Seeing weakness in company. Despite car maintenance going up, company not performing. Has sold shares.
Better option than BCE. Has stronger growth profile. Lots of capital required for business. Rates for mobile use falling (not as much revenues). Would wait until stock reaches bottom. Trend has not reversed yet. Buy on weakness. If interest rates are cut, will also help the company.
Recent trend indicating downward pressure. Competition on weight loss drugs making it hard to generate profits. Seasonal perspective - a good time to buy pharma stocks. Expecting stock to appreciate going forward.
Excellent dividend with oligopoly market position. Would recommend holding position. Recent pressure on stock creating a buying opportunity. Anti-money laundering lawsuit a short term concern. Long term - is a great investment.
Recent pullback was a good opportunity to buy. Recent uptrend is good for investors. From a technical perspective - good time to buy.
Seasonality not a guarantee to buy or sell. Despite being "out of season" - could trend upwards. Expecting strength from silver in July. Recent up trend in silver a good sign for investors. Overall, would wait until July before investing.
M&A activity very strong in the past. Excellent management team with sharp capital allocation skills. Compounded rate on investment has been good for investors. If economy falls into recession, not goof for business. Would recommend holding shares, but not adding at this time.
Company has been range bound for ~10-15 years. Recent strength in stock price good for investors. Higher interest rates good for investors. If interest rates fall, not good for business. Would recommend holding shares.
Health care sector seeing strength. Good for investors. From technical perspective, stock has broken down - not performing well. Overall, is a strong business. Would buy on weakness. Weakness in share price, a good time to buy.